LOG IN OR SIGN UP TO "MY Eu2P"Organization for risk management in the industry
OBJECTIVESThis course aims, based on the experience of a large international pharmaceutical company, to define the general principles necessary to build a process for developing Risk Management Plans for a medicinal product by the Industry.
LEARNING OUTCOMESAt the end of the course, you will be able to know the main principles for establishing a Risk Management Plan process in a pharmaceutical company.
|
|
||||||||||||
AUTHORS
|
Dr. Katia Verhamme Erasmus Universitair Medisch Centrum |
|
Dr. Laurent Auclert Sanofi-aventis Recherche et Développement |
